Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- High Seroprevalence of anti-Hepatitis E antibodies in Austrian patients with Autoimmune Hepatitis.
- Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
- [Radiologic diagnosis of the gallbladder and bile ducts - part 2 : Acute and chronic cholecystitis, primary sclerosing cholangitis (PSC), benign and malignant masses of the biliary system].
- Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance.
- Diagnosis and Management of Primary Biliary Cholangitis.
- Initial presentation determines clinical entity in patients with anti-centromere antibody positivity.
- False negative and false positive rates in common bile duct brushing cytology, a single center experience.
- Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis.
- Autoimmune Liver Diseases in Children.
- Prognostic models in primary biliary cholangitis.
- Effect of NGM282, a FGF19 analogue, in Primary Sclerosing Cholangitis: a Multicentre, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
- Isolated renal mucormycosis in a patient with Idiopathic CD4 lymphocytopenia.
- FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.
- Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
- H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α+ Periportal Hepatocytes but Not Cytokeratin 19+ Cholangiocytes in Cholestatic Livers.
- Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune Hepatitis.
- The epidermal growth factor receptor ligand amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis.
- Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature.
- Novel therapeutic targets in autoimmune hepatitis.
- Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.
- Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in patients with Inflammatory Bowel Disease.
- Animal models of cholestasis: An update on inflammatory cholangiopathies.
- De novo autoimmune hepatitis -is this different in adults compared to children?
- Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score.
- Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
- Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis.
- Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis.
- Etiopathogenesis of autoimmune hepatitis.
- [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
- Comorbidity of localized scleroderma and primary biliary cholangitis.
- Individual probe based confocal laser endomicroscopy criteria in the analysis of indeterminate biliary strictures.
- Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
- Autoimmune Hepatitis in Pregnancy: Hematological Perturbation and Management Dilemma. A Case Report.
- High serum sCD40 and a distinct colonic T-cell profile in ulcerative colitis associated with primary sclerosing cholangitis.
- Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children.
- Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis (PBC) in Young patients: Analysis of the United Network for Organ Sharing Database.
- Recurrent and de novo autoimmune hepatitis.
- Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
- [Gut-liver axis: How intestinal bacteria affect the liver].
- The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
- Autoimmune sclerosing cholangitis: Evidence and open questions.
- Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: a single center follow-up study from China.
- Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
- Clinical presentation of autoimmune hepatitis in Pakistani children.
- Acute Liver Failure due to Disseminated Varicella Zoster Infection.
- Effects of liver transplantation on health-related quality of life in patients with primary biliary cholangitis (PBC).
- Extrahepatic autoimmunity in autoimmune liver disease.
- Role of TGR5 (GPBAR1) in Liver Disease.
- ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
- [Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial].
- Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis.
- Case Report: Acute Hepatitis E in a Pediatric Traveler Presenting with Features of Autoimmune Hepatitis: A Diagnostic and Therapeutic Challenge.
- Acute severe hepatitis with alemtuzumab and rechallenge after a year.
- Juvenile autoimmune hepatitis: A comprehensive review.
- Risk stratification and prognostic modelling in primary biliary cholangitis.
- Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.
- Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC).
- Primary biliary cholangitis and bone disease.
- Variant syndromes of primary biliary cholangitis.
- PBC and related extrahepatic diseases.
- Symptoms of PBC - Pathophysiology and management.
- Evolution of our understanding of PBC.
- Is PBC a viral infectious disease?
- Pathophysiology of primary biliary cholangitis.
- Geoepidemiology and (epi-)genetics in primary biliary cholangitis.
- PBC-transplantation and disease recurrence.
- Preface - Primary Biliary Cholangitis.
- Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant.
- Unique patterns of glycosylation in IgG4-related disease and primary sclerosing cholangitis.
- Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis.
- Esophageal Ulcers in Primary Biliary Cholangitis: A Rare Cause of Hematemesis in the Setting of Portal Hypertension and Esophageal Varices.
- Gut microbiota translocation promotes autoimmune cholangitis.
- Liver diseases in the elderly.
- A Histologically Proven Case of Autoimmune Hepatitis with Eosinophilic Fasciitis.
- Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
- Risk stratification and treatment of primary biliary cholangitis.
- High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy.
- Autoimmune liver disease serology in acute hepatitis E virus infection.
- In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response.
- Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis.
- Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.
- Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis in the Tunisian population.
- Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients.
- Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis-Authors' reply.
- Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis.
- [Diagnosis and differential diagnosis of immunoglobulin G4-related hepatobiliary disease].
- [Histopathological features and pathological diagnosis of IgG4-related hepatobiliary diseases].
- [Research status and challenges in immunoglobulin G4-related hepatobiliary disease].
- Non-invasive Prediction of High-risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
- Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease.
- [Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect].
- Retrospectively Seroprevalence Study on Anti-HEV-IgG antibody in patients with chronic hepatitis or liver cirrhosis in a Chinese teaching hospital.
- IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy.
- Is this the Last Requiem for Simtuzumab? - "Blessed is who expects nothing, for he shall never be disappointed." - Alexander Pope.
- Acute Kidney Injury Due to Inferior Vena Cava Stenosis After Liver Transplantation: A Case Report About the Importance of Hepatic Vein Doppler Ultrasound and Clinical Assessment.
- De Novo Autoimmune Hepatitis After Living Donor Liver Transplantation: A Series of 4 Cases.
- Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling.
- Analysis of predictive response scores to treatment with ursodeoxycholic acid in patients with primary biliary cholangitis.
- Risk factors for extrahepatic cholangiocarcinoma: a case-control study in China.
- Upper Extremity Compartment Syndrome Following Radial Artery Puncture in a Patient Undergoing Orthotopic Liver Transplant.
- Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
- Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.
- Association of STAT4, TGFβ1, SH2B3 and PTPN22 polymorphisms with autoimmune hepatitis.
- Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
- Management of primary biliary cholangitis: the importance to identify patients non-responders to standard treatment.
- Inhibition of microRNA-155 attenuates concanavalin A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation.
- Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report.
- [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
- Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
- Standardization of Autoantibody Testing in Autoimmune Hepatitis.
- Pernicious anemia associated with cryptogenic cirrhosis: Two case reports and a literature review.
- Renal complications of liver diseases.
- Sex-related factors in autoimmune liver diseases.
- Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
- Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
- Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients?
- Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
- Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.
- Cirrhosis and Portal Hypertension in the Pediatric Population.
- Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
- The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis.
- An 8-Year-Old Girl with Autoimmune Hepatitis Following Aplastic Anemia.
- Primary Biliary Cholangitis: A New Era.
- Primary Biliary Cholangitis.
- Current Status of Liver Transplantation for Primary Biliary Cholangitis.
- Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis.
- Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?
- Liver Biopsy in Primary Biliary Cholangitis: Indications and Interpretation.
- Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems.
- Individualizing Care: Management Beyond Medical Therapy.
- Chronic Complications of Cholestasis: Evaluation and Management.
- Understanding and Treating Pruritus in Primary Biliary Cholangitis.
- Work in Progress: Drugs in Development.
- Current Treatment Options for Primary Biliary Cholangitis.
- Role of Bile Acids and the Biliary HCO3- Umbrella in the Pathogenesis of Primary Biliary Cholangitis.
- The Genetics and Epigenetics of Primary Biliary Cholangitis.
- Changes in the Epidemiology of Primary Biliary Cholangitis.
- miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis.
- Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells.
- Circulating liver-specific microRNAs as non-invasive diagnostic biomarkers of hepatic diseases in human.
- Overexpression of KLF14 protects against immune-mediated hepatic injury in mice.
- Prompt initiation of high-dose intravenous corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis.
- Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.
- Cholangiopathies - Towards a molecular understanding.
- A Lower 6MMP/6TG Ratio may be a Therapeutic Target in Pediatric Autoimmune Hepatitis.
- Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype.
- Cross-species molecular imaging of bile salts and lipids in liver: identification of molecular structural markers in health and disease.
- Real-world management of juvenile autoimmune liver disease.
- Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis.
- Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom.
- Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
- PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.
- Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
- An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection.
- Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: a Danish nationwide cohort study.
- Primary biliary cholangitis associated with drug-induced liver injury and alcoholic liver fibrosis: A case report.
- [A Case of Brain Abscess Caused by Nocardia farcinica in which the Test Results for Drug Susceptibility Conflicted with the Actual Clinical Course].
- The usefulness of transient elastography in patients with autoimmune hepatitis-when can we use it?
- Immunoglobulin G4 Sclerosing Cholangitis: An Unusual Cause of Obstructive Jaundice-Case Report and Literature Review.
- Bezafibrate in Primary Biliary Cholangitis.
- Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use.
- Autoimmune hepatitis exerts a profound, negative effect on health related quality of life: a prospective, single centre study.
- Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
- Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
- NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
- Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?
- Liver transplantation in the management of perihilar cholangiocarcinoma.
- Aggressive systemic mastocytosis of the liver with cholangitis.
- Drug-Induced Autoimmune Hepatitis in a Patient Treated with Minocycline: A Rare Adverse Effect.
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
- Bezafibrate in Primary Biliary Cholangitis.
- Undiagnosed autoimmune hepatitis causing prolonged mechanical ventilation.
- Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy.
- Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.
- Pediatric autoimmune liver disease and extra-hepatic immune-mediated comorbidities.
- Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn's disease.
- Cholestatic liver diseases: new targets, new therapies.
- The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis.
- PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
- Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
- [Primary biliary cholangitis : an update].
- Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise?
- Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Authors' reply.
- Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.
- Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study.
- Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.
- [Hepatocellular damage, proteinuria and autoimmunity: multisystemic disorder or coexistence of diseases?]
- Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database.
- Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis.
- Diagnosis of primary biliary cholangitis in a "teen" male patient.
- Inactivation of Caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis.
- Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.
- Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis.
- Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
- Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis.
- Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.
- Osteoporosis in primary biliary cholangitis.
- Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
- Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.
- Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
- Autoimmune hepatitis in children.
- Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients.
- Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.